{"id":"https://openalex.org/W7225177384","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0401","title":"401 genO-hCCR8/hCCL1/hFc\u03b3R preclinical mouse model for efficacy assessment of CCR8-targeting agents","display_name":"401 genO-hCCR8/hCCL1/hFc\u03b3R preclinical mouse model for efficacy assessment of CCR8-targeting agents","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7225177384","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0401"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0401","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0401","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0401","pdf_url":null,"source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0401","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083091753","display_name":"Angela Pappalardo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100708","display_name":"Genoway (France)","ror":"https://ror.org/017r9q421","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210100708"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Angela Pappalardo","raw_affiliation_strings":["genOway, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"genOway, Lyon, France","institution_ids":["https://openalex.org/I4210100708"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029338047","display_name":"Ga\u00eblle Martin","orcid":"https://orcid.org/0000-0001-8849-9413","observed_orcids":["https://orcid.org/0000-0001-8849-9413"]},"institutions":[{"id":"https://openalex.org/I4210100708","display_name":"Genoway (France)","ror":"https://ror.org/017r9q421","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210100708"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Gaelle Martin","raw_affiliation_strings":["genOway, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"genOway, Lyon, France","institution_ids":["https://openalex.org/I4210100708"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113464973","display_name":"Patricia Isnard","orcid":"https://orcid.org/0009-0003-6046-2135","observed_orcids":["https://orcid.org/0009-0003-6046-2135"]},"institutions":[{"id":"https://openalex.org/I4210100708","display_name":"Genoway (France)","ror":"https://ror.org/017r9q421","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210100708"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Patricia Isnard-Petit","raw_affiliation_strings":["genOway, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"genOway, Lyon, France","institution_ids":["https://openalex.org/I4210100708"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014664769","display_name":"Yacine Ch\u00e9rifi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100708","display_name":"Genoway (France)","ror":"https://ror.org/017r9q421","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210100708"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Yacine Cherifi","raw_affiliation_strings":["genOway, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"genOway, Lyon, France","institution_ids":["https://openalex.org/I4210100708"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030019517","display_name":"Fabiane S\u00f4nego","orcid":"https://orcid.org/0009-0004-9133-706X","observed_orcids":["https://orcid.org/0009-0004-9133-706X"]},"institutions":[{"id":"https://openalex.org/I4210100708","display_name":"Genoway (France)","ror":"https://ror.org/017r9q421","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210100708"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Fabiane Sonego","raw_affiliation_strings":["genOway, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"genOway, Lyon, France","institution_ids":["https://openalex.org/I4210100708"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043201177","display_name":"Kader Thiam","orcid":"https://orcid.org/0009-0004-2480-5249","observed_orcids":["https://orcid.org/0009-0004-2480-5249"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kader Thiam","raw_affiliation_strings":["genOway, Rhone Alpes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"genOway, Rhone Alpes, France","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A447","last_page":"A447"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11532","display_name":"Chemokine receptors and signaling","score":0.6567000150680542,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11532","display_name":"Chemokine receptors and signaling","score":0.6567000150680542,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.13330000638961792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.12409999966621399,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ccr8","display_name":"CCR8","score":0.9919999837875366},{"id":"https://openalex.org/keywords/ccl1","display_name":"CCL1","score":0.9909999966621399},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.8629999756813049},{"id":"https://openalex.org/keywords/humanized-mouse-model","display_name":"humanized mice","score":0.7799999713897705},{"id":"https://openalex.org/keywords/fc-gamma-receptor","display_name":"Fc gamma receptor","score":0.6439999938011169},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.593999981880188},{"id":"https://openalex.org/keywords/tumor-infiltrating-treg-cells","display_name":"tumor-infiltrating Treg cells","score":0.6349999904632568},{"id":"https://openalex.org/keywords/mc38-colon-carcinoma","display_name":"MC38 colon carcinoma","score":0.7289999723434448},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.6050000190734863}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8125},{"id":"https://openalex.org/C2994543053","wikidata":"https://www.wikidata.org/wiki/Q7239206","display_name":"Preclinical testing","level":2,"score":0.4797999858856201},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.38350000977516174},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3499000072479248},{"id":"https://openalex.org/C2993043200","wikidata":"https://www.wikidata.org/wiki/Q7239206","display_name":"Preclinical research","level":2,"score":0.34369999170303345},{"id":"https://openalex.org/C2779446555","wikidata":"https://www.wikidata.org/wiki/Q7663877","display_name":"Systems pharmacology","level":3,"score":0.2793999910354614},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.2732999920845032},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.26750001311302185},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.26589998602867126},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.2648000121116638}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2026-sitc2026.0401","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0401","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0401","pdf_url":null,"source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:1f0b8c5922e14365a2861454b4a64542","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/1f0b8c5922e14365a2861454b4a64542","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 14, Iss Suppl 2 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0401","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0401","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0401","pdf_url":null,"source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4415898980","https://openalex.org/W4200495940","https://openalex.org/W4388084139","https://openalex.org/W4409633329","https://openalex.org/W3182059173","https://openalex.org/W2792070967","https://openalex.org/W6979917958","https://openalex.org/W4390946716","https://openalex.org/W3182834127","https://openalex.org/W2112183767"],"abstract_inverted_index":{"Background":[0],"CCR8":[1,38,81,101,190,265,300,417],"is":[2],"an":[3],"emerging":[4],"therapeutic":[5,111],"target":[6],"in":[7,13,57,82,127,162,259,272,284,304,321,381,469,634],"oncology":[8],"due":[9],"to":[10,23,116,239,599],"its":[11,36],"role":[12],"Treg-mediated":[14],"immunosuppression.":[15],"The":[16,228,354,376],"development":[17],"of":[18,29,66,87,99,107,141,170,207,216,248,262,278,327,347,349,365,378,392,596,626],"physiologically":[19],"relevant":[20,637],"preclinical":[21],"models":[22,143],"evaluate":[24],"CCR8-targeting":[25,279,350,366],"therapies":[26,367],"requires":[27],"preservation":[28],"functional":[30],"interactions":[31],"between":[32,133],"the":[33,88,138,197,205,236,241,249,260,273,317,325,334,363,373,382,615,623,642,646,653],"receptor":[34,120],"and":[35,44,96,102,130,135,160,187,191,246,292,309,323,341,345,368,594,628,632,639,652],"ligands.":[37],"has":[39,113],"two":[40],"known":[41],"ligands,":[42],"CCL1":[43,75,192,256],"CCL8.":[45],"Previous":[46],"studies":[47,342],"have":[48],"shown":[49,115],"that":[50,64,85],"mouse":[51,142,145,152,209],"CCL8":[52,67],"can":[53],"induce":[54],"calcium":[55],"flux":[56],"human":[58,80,155,202,255,470],"CCR8-transfected":[59],"murine":[60,74,198],"cells,":[61],"1":[62],"suggesting":[63],"humanization":[65,98,595],"may":[68,91],"not":[69,77],"be":[70],"required.":[71],"In":[72,104,333],"contrast,":[73],"does":[76],"interact":[78],"with":[79,200,235,288,636],"vitro,":[83],"indicating":[84],"disruption":[86],"CCR8/CCL1":[89,250],"axis":[90,251],"impair":[92],"Treg":[93],"suppressive":[94],"function":[95],"necessitate":[97],"both":[100],"CCL1.":[103],"addition,":[105],"depletion":[106],"CCR8+":[108],"Tregs":[109,271,303],"by":[110,195,389,422,614,622],"agents":[112,351],"been":[114],"depend":[117],"on":[118,175,269,302],"Fc\u03b3":[119,597],"(Fc\u03b3R)":[121],"engagement.2":[122],"However,":[123,299],"significant":[124,285],"interspecies":[125],"differences":[126],"Fc\u03b3R":[128,151],"repertoire":[129],"expression":[131,266,301,318],"patterns":[132],"mice":[134],"humans":[136,322],"limit":[137],"translational":[139,387],"relevance":[140,388],"expressing":[144,154,183],"Fc\u03b3R.":[146],"A":[147],"previously":[148],"described":[149],"humanized":[150,181,184,194,379],"model":[153,182,231,238,329,356,384],"Fc\u03b3RI,":[156],"Fc\u03b3RIIA,":[157],"Fc\u03b3RIIB,":[158],"Fc\u03b3RIIIA,":[159],"Fc\u03b3RIIIB":[161],"a":[163,179,358,416],"human-like":[164],"distribution":[165],"enables":[166],"more":[167],"accurate":[168],"evaluation":[169,277,391],"Fc-mediated":[171,393],"immune":[172],"responses.3":[173],"Building":[174],"this,":[176],"we":[177],"developed":[178],"novel":[180],"CCR8,":[185],"CCL1,":[186],"Fc\u03b3Rs":[188,380],"(genO-hCCR8/hCCL1/Fc\u03b3R).Methods":[189],"were":[193,223,252,611],"replacing":[196],"genes":[199],"their":[201],"counterparts":[203],"under":[204],"control":[206],"endogenous":[208],"promoters.":[210],"This":[211],"strategy":[212],"preserves":[213],"physiological":[214],"regulation":[215],"gene":[217,226],"expression,":[218],"as":[219],"no":[220],"regulatory":[221,466],"elements":[222],"altered":[224],"during":[225],"editing.":[227],"resulting":[229],"genO-hCCR8/hCCL1":[230,263,355],"was":[232,257,267,311],"subsequently":[233],"crossed":[234],"genO-hFc\u03b3R":[237],"generate":[240],"triple-humanized":[242],"genO-hCCR8/hCCL1/Fc\u03b3R":[243,335,383],"strain.Results":[244],"Expression":[245],"functionality":[247],"confirmed:":[253],"Circulating":[254],"detected":[258],"serum":[261],"mice.":[264],"observed":[268,320],"tumor-infiltrating":[270],"MC38":[274,337],"model,":[275,336],"enabling":[276,390],"depleting":[280],"antibodies.":[281],"Treatment":[282],"resulted":[283],"antitumor":[286],"activity,":[287],"reduced":[289],"tumor":[290,374,471],"volume":[291],"improved":[293],"survival":[294],"at":[295],"20":[296],"days":[297],"post-inoculation.":[298],"peripheral":[305],"tissues":[306],"(spleen,":[307],"skin,":[308],"blood)":[310],"low":[312],"or":[313],"absent,":[314],"differing":[315],"from":[316],"pattern":[319],"limiting":[324],"utility":[326],"this":[328],"for":[330,361],"safety":[331],"assessment.":[332],"tumors":[338],"established":[339],"successfully,":[340],"evaluating":[343],"efficacy":[344,364],"mechanism":[346],"action":[348],"are":[352],"ongoing.Conclusions":[353],"represents":[357],"valuable":[359],"platform":[360],"assessing":[362],"investigating":[369],"immunomodulatory":[370],"mechanisms":[371],"within":[372],"microenvironment.":[375],"addition":[377],"further":[385],"enhances":[386],"effector":[394],"functions.References":[395],"Islam":[396],"SA,":[397,409],"Chang":[398],"DS,":[399],"Colvin":[400],"RA,":[401],"Byrne":[402],"MH,":[403],"McCully":[404],"ML,":[405],"Moser":[406],"B,":[407,527,588],"Lira":[408],"Charo":[410],"IF,":[411],"Luster":[412],"AD.":[413],"Mouse":[414],"CCL8,":[415],"agonist,":[418],"promotes":[419],"atopic":[420],"dermatitis":[421],"recruiting":[423],"IL-5":[424],"+":[425],"T(H)2":[426],"cells.":[427],"Nat":[428],"Immunol.":[429,604],"2011;12:167\u2013177.Campbell":[430],"JR,":[431],"McDonald":[432],"BR,":[433],"Mesko":[434],"PB,":[435,439],"Siemers":[436],"NO,":[437],"Singh":[438],"Selby":[440],"M,":[441,513],"Sproul":[442],"TW,":[443],"Korman":[444,559],"AJ,":[445,560],"Vlach":[446],"LM,":[447],"Houser":[448],"J,":[449,457,486,491,537],"Sambanthamoorthy":[450],"S,":[451,489,494,516,544,548,550,552,556,566,586],"Lu":[452],"K,":[453,483,535,584],"Hatcher":[454],"SV,":[455],"Lohre":[456],"Jain":[458],"R,":[459,531,546],"Lan":[460],"RY.":[461],"Fc-optimized":[462],"anti-CCR8":[463],"antibody":[464,601],"depletes":[465],"T":[467],"cells":[468],"models.":[472],"Cancer":[473],"Res.":[474],"2021;81:2983\u20132994.Van":[475],"Damme":[476],"KFA,":[477],"Sichien":[478],"D,":[479,564,574],"Van":[480,484,487,524],"der":[481],"Borght":[482],"Moorleghem":[485],"Gassen":[488],"Jorssen":[490],"De":[492,495,509,514,519],"Winter":[493],"Leeuw":[496],"E,":[497,580],"Wang":[498],"C,":[499,521,572],"Chai":[500],"Q,":[501],"Brotcke":[502],"Zumsteg":[503],"A,":[504,518,578],"Schmid":[505],"MA,":[506],"Bosteels":[507],"V,":[508],"Bleser":[510],"P,":[511,542],"Vanheerswynghels":[512],"Prijck":[515],"Bujko":[517],"Nolf":[520],"Schuijs":[522],"MJ,":[523],"Den":[525],"Eeckhout":[526],"Rogiers":[528],"I,":[529],"Browaeys":[530],"Thielemans":[532],"F,":[533,562,582],"Quintelier":[534],"D\u2019Hont":[536],"Hochepied":[538],"T,":[539],"Isnard":[540],"Petit":[541],"Augier":[543],"Courtois":[545],"Verwaerde":[547],"Vanhee":[549],"Schetters":[551],"Scott":[553],"CL,":[554],"Aerts":[555],"Saeys":[557],"Y,":[558],"Benigni":[561],"Corti":[563],"Janssens":[565],"Vandamme":[567],"N,":[568],"Baptista":[569],"AP,":[570],"Desmet":[571],"Elewaut":[573],"Hammad":[575],"H,":[576],"Morel":[577],"Vivier":[579],"S\u00f4nego":[581],"Thiam":[583],"Voet":[585],"Balbino":[587],"Lambrecht":[589],"BN.":[590],"Cross-species":[591],"cellular":[592],"mapping":[593],"receptors":[598],"advance":[600],"modeling.":[602],"Sci":[603],"2026;11:eady7328.Ethics":[605],"Approval":[606],"All":[607],"animal":[608],"experimental":[609],"procedures":[610],"ethically":[612],"approved":[613],"ethical":[616],"committee":[617],"VetAgro":[618],"Sup":[619],"n\u00b0018,":[620],"validated":[621],"French":[624,648],"Ministry":[625],"Education":[627],"Research":[629],"(APAFiS":[630],"#38722)":[631],"performed":[633],"line":[635],"guidelines":[638],"regulations":[640],"including":[641],"EU":[643],"Directive":[644],"2010/63/EU,":[645],"related":[647],"de\u00edcret":[649],"n\u00b0":[650],"2013-118,":[651],"3Rs":[654],"(Refinement,":[655],"Reduction,":[656],"Replacement).":[657]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-11-04T00:00:00"}